Cargando…
Effects of tiotropium on the risk of coronary heart disease in patients with COPD: a nationwide cohort study
Inhaled long-acting muscarinic antagonist (LAMA) is recommended for the treatment of chronic obstructive pulmonary disease (COPD). However, there is still concern that LAMA may cause cardiovascular adverse events in COPD patients. Therefore, this study aimed to determine whether the administration o...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535029/ https://www.ncbi.nlm.nih.gov/pubmed/36198721 http://dx.doi.org/10.1038/s41598-022-21038-1 |